Keith Riccardi

BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents

Brett S. Robinson, Keith Riccardi, Yi-Fei Gong et al. · Antimicrobial Agents and Chemotherapy · 2000 · 196 citations

Medicine, Infectious Diseases, Pharmacology +17

Systematic Evaluation of Bioorthogonal Reactions in Live Cells with Clickable HaloTag Ligands: Implications for Intracellular Imaging

Heather E. Murrey, Joshua C. Judkins, Christopher W. am Ende et al. · Journal of the American Chemical Society · 2015 · 189 citations · Full text

Pharmacy, Cell Biology, Chemical Biology +13

Plasma Protein Binding of Challenging Compounds

Keith Riccardi, Shannon Cawley, Phillip D. Yates et al. · Journal of Pharmaceutical Sciences · 2015 · 117 citations

Pharmacy, Biochemistry, Pharmacology +12

A “middle-out” approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling

Rui Li, Hugh A. Barton, Phillip D. Yates et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2014 · 77 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5)

Kim Huard, Janice A. Brown, Jessica Jones et al. · Scientific Reports · 2015 · 70 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11